Can multiple myeloma be misdiagnosed? Is multiple myeloma an autoimmune disorder? What causes hypercalcemia in multiple myeloma? What are the symptoms of advanced multiple myeloma? What is the test for multiple myeloma? What is the difference between leukemia and multiple myeloma?
High-dose melphalan with autologous bone marrow transplantation for multiple myeloma Blood, 67 (5) (1986), pp. 1298-1301 View in ScopusGoogle Scholar 17. SZ Usmani, A Hoering, M Cavo Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma - an IMWG re...
Multiple myeloma, a malignant proliferation of plasma cells, is still incurable. This disease, 1% of all human malignancies, is responsible for almost 2 % of the whole cancer related mortality. In this review the authors summarize their 20 years experience in the field of myeloma research aiming...
Suzanne Lentzsch, MD, discusses how patient age informs treatment decisions in multiple myeloma. This is a modal window. This video is either unavailable or not supported in this browser Error Code: MEDIA_ERR_SRC_NOT_SUPPORTED Technical details : No compatible source was found for this m...
Diagnosed with Multiple Myeloma: 10 Tips on How to Get The Most From Your Doctor By CancerConnectMar 16, 2019 Colon Cancer Treatment Diagnosed with Colon Cancer: 10 Tips on How to Get The Most From Your Doctor Ten things every patient with colon cance...
recently co-authoreda systemic reviewof global health disparities among MM patients.6Multiple studies included in the review found that Black individuals are more likely than white individuals to be diagnosed with MM, and they are typically younger at disease onset, even though MM is usually ...
What is DARZALEX FASPRO®? DARZALEX FASPRO® is a prescription medicine used to treat adult patients with multiple myeloma: in combination with the medicines bortezomib, lenalidomide, and dexamethasone in newly diagnosed people who are eligible to receive a type of stem cell transplant that uses ...
If AA is diagnosed on the basis of histology, focused history and investigations are required to identify the underlying cause of chronic inflammation, a necessary prerequisite for the diagnosis. Serial measurement of the acute phase protein SAA (or C-reactive protein as a surrogate) is required ...
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma: a series of 144 cases and a review of the literature. Ann Hematol 2011; 90: 101–106. Article CAS Google Scholar Kyle ...
This article presents a practical overview of the treatment of younger, newly diagnosed multiple myeloma patients, focusing on novel treatment strategies. With the introduction of effective new agents, multiple myeloma is one of the most active and changing fields in clinical oncology. In addition, ...